Cross-cultural differences in demented geropsychiatric inpatients with behavioral disturbances

International Journal of Geriatric Psychiatry

Volumn 14, Issue 10, 1999, Pages 845-850

  Akpaffiong, Macjohn ^a   Kunik, Mark E ^b,c   Hale, Danielle ^d   Molinari, Victor ^b   Orengo, Claudia ^c  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

Behavioral disturbances; Dementia; Ethnicity; Interdisciplinary treatment approach

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HALOPERIDOL; LOXAPINE SUCCINATE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CAUCASIAN; CULTURAL FACTOR; DEMENTIA; ETHNOLOGY; FEMALE; GERONTOPSYCHIATRY; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEGRO; ORAL DRUG ADMINISTRATION; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BRIEF PSYCHIATRIC RATING SCALE; CROSS-CULTURAL COMPARISON; CULTURE; DEMENTIA; DEPRESSIVE DISORDER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES FOR THE AGED; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT CARE TEAM; PSYCHOMOTOR AGITATION; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0032726946     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199910)14:10<845::AID-GPS34>3.0.CO;2-H     Document Type: Article

References (38)

1. Adebimpe, V. R. (1981) Overview: White norms and psychiatric diagnosis of black patients. Am. J. Psychiat. 138, 279-285.
2. Adebimpe, V. R., Klein, H. E. and Fried, J. (1987) Hallucinations and delusions in black psychiatric patients. J. Nat. Med. Assoc. 73, 517-520.
3. American Psychiatric Association (1995) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition: Primary Care Version. American Psychiatric Association, Washington, DC.
4. Asberg, M., Cronholm, B., Sjogvist, F. and Tuck, D. (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. Brit. Med. J. 4, 18-21.
5. Berrios, G. E. (1994) Dementia: Historical overview. In Dementia (A. Burns and R. Levy, Eds). Chapman and Hall, London, pp. 5-19.
6. Chu, C. C., Sallach, H. S., Zakeria, S. A. and Klein, H. E. (1985) Differences in psychopathology between black and white schizophrenics. Int. J. Soc. Psychiat. 31, 252-257.
7. Chung, H., Mahler, J. C. and Kakuna, T. (1995) Racial differences in treatment of psychiatric inpatients. Psychiatr. Serv. 46, 586-591.
8. Cohen, C. I. and Carlin, L. (1993) Racial differences in clinical and social variables among patients evaluated in a dementia assessment center. J. Nat. Med. Assoc. 85, 379-384.
9. Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989) A description of agitation in a nursing home. J. Gerontol. 44, M77-M84.
10. Cooper, J. K., Mungas, D. and Weiler, P. G. (1990) Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J. Am. Geriatr. Soc. 38, 867-870.
11. Duara, R., Barker, W. W., Lopez-Alberola, R. and Loewenstein, D. A. (1996) Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 46, 1575-1579.
12. Eastwood, R. (1997) Dementia: Current developments. Biomed. Pharmacother. 51, 112-117.
13. Fabrega, H. Jr, Mezzich, J. and Ulrich, R. F. (1988) Black-white differences in psychopathology in an urban psychiatric population. Compr. Psychiat. 29, 285-297.
14. Farlow, M. R. (1997) Alzheimer's disease: Clinical implications of the apolipoprotein E genotype. Neurology 48, S30-S34.
15. Flaherty, J. A. and Meagher, R. (1980) Measuring racial bias in inpatient treatment. Am. J. Psychiat. 137, 679-682.
16. Flint, A. J. (1991) Delusions in dementia: A review. J. Neuropsychiat. Clin. Neurosci. 3, 121-130.
17. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975) 'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
18. Gorham, D. R. and Overall, J. E. (1960) Drug-action profiles based on an abbreviated psychiatric rating scale. J. Nerv. Mem. Dis. 131, 528-535.
19. Hamilton, M. (1960) A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 23, 56-62.
20. Hargrave, R., Stoeklin, M., Haan, M. and Reed, B. (1998) Clinical aspects of Alzheimer's disease in black and white patients. J. Nat. Med. Assoc. 90, 78-84.
21. Heyman, A., Fillenbaum, G., Prosnitz, B., Raiford, K., Burchett, B. and Clark, C. (1991) Estimated prevalence of dementia among elderly black and white community residents. Arch. Neurol. 48, 594-598.
22. Jeste, D. V., Lindamer, L. A., Evans, J. and Larco, J. P. (1996) Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics. Psychopharmacol. Bull. 32, 243-251.
23. Jones, B. E. and Gray, B. A. (1986) Problems diagnosing schizophrenia and affective disorders among blacks. Hosp. Commun. Psychiat. 37, 61-65.
24. Jorm, A. F., Korten, A. E. and Henderson, A. S. (1987) The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr. Scand. 76, 465-479.
25. Kay, S. R. (1991) Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Brunner/ Mazel, New York.
26. Kunik, M. E., Puryear, L., Orengo, C. A., Molinari, V. and Workman, R. H. Jr (1996a) Trazodone for sleep and agitation in a geropsychiatry inpatient unit. Nurs. Home Med. 4, 255-259.
27. Kunik, M. E., Silver, J. M. and Bhandary, A. et al. (1996b) Assessment and treatment of agitation in patients with dementia. In Practical Clinical Strategies in Treating Depression and Anxiety Disorders in a Managed Care Environment (R. Hales and S. Yudofsky, Eds). American Psychiatric Association, Washington, DC, pp. 49-54.
28. Kunik, M. E., Puryear, L., Orengo, C. A., Molinari, V. and Workman, R. H. Jr (1998) The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances. Int. J. Geriatr. Psychiat. 13, 29-34.
29. Lawson, W. B., Helper, N., Holladay, J. and Cuffel, B. (1994) Race as a factor in inpatient and outpatient admissions and diagnosis. Hosp. Commun. Psychiat. 45, 72-74.
30. Lin, K. M., Poland, R. E., Nuccio, I., Matsuda, K., Hathuc, N., Su, T. P. and Fu, P. (1989) A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am. J. Psychiat. 146, 1307-1311.
31. Mega, M. S., Cummings, J. L., Fiorello, T. and Gornbein, J. (1996) The spectrum of behavioral changes in Alzheimer's disease. Neurology 46, 130-135.
32. Raskind, M. A. (1995) Alzheimer's disease: Treatment of noncognitive behavioral abnormalities. In Psychopharmacology: The Fourth Generation of Progress (F. E. Bloom and D. J. Kupfer, Eds). Raven Press, New York, pp. 1427-1435.
33. Raskind, M. A. and Peskind, E. R. (1994) Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alz. Dis. Assoc. Disord. 8, Suppl. 3, 54-60.
34. Schoenberg, B. S., Anderson, D. W. and Haerer, A. F. (1985) Severe dementia. Prevalence and clinical features in a biracial US population. Arch. Neurol. 42, 740-743.
35. Simon, R. J., Fleiss, J. L., Gurland, B. J., Stiller, P. R. and Sharpe, L. (1973) Depression and schizophrenia in hospitalized black and white mental patients. Arch. Gen. Psychiat. 28, 509-512.
36. Slooter, A. J. C., Tang, M. X., van Duijn, C. M. and Stern, Y. (1997) Apolipoprotein E 4 and the risk of dementia with stroke: A population-based investigation. JAMA 277, 818-821.
37. Strakowski, S. M., Lonczak, H. W., Sax, K. W., West, C. A., Crist, A., Mehta, R. and Thienhaus, O. J. (1995) The effects of race on diagnosis and disposition from a psychiatry emergency service. J. Clin. Psychiat. 56, 101-107.
38. Strickland, T. K., Ranganath, V., Lin, K. M., Poland, R. E., Mendoza, R. and Smith, M. W. (1991) Psychopharmacologic considerations in the treatment of black American populations. Psychopharmacol. Bull. 27, 441-448.